Managing substance dependence as a chronic disease: Is the glass half full or half empty?

JAMA

Volumn 310, Issue 11, 2013, Pages 1132-1134

  O'Connor, Patrick G ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BUPRENORPHINE; ILLICIT DRUG; NALTREXONE;

ADDICTION; ALCOHOLISM; BINGE DRINKING; COMORBIDITY; DRUG DEPENDENCE; ECONOMIC ASPECT; EDITORIAL; HEALTH CARE COST; HEALTH CARE SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SUBSTANCE ABUSE; UNITED STATES;

EID: 84884187522     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2013.277610     Document Type: Editorial

References (18)

1. World Health Organization. Global Status Report on Alcohol and Health. Geneva, Switzerland: World Health Organization; 2011.
2. Bouchery EE, Harwood HJ, Sacks JJ, Simon CJ, Brewer RD. Economic costs of excessive alcohol consumption in the US, 2006. Am J Prev Med. 2011;41(5):516-524.
3. Substance Abuse and Mental Health Services Administration. Results from the 2011 National Survey on Drug Use and Health: Summary of National Findings. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2012. DHHS publication (SMA) 12-4713.
4. Kloss JD, Lisman SA. Clinician attributions and disease model perspectives of mentally ill, chemically addicted patients: a preliminary investigation. Subst Use Misuse. 2003;38(14):2097-2107. (Pubitemid 37499740)
5. McKay JR, Hiller-Sturmhofel S. Treating alcoholism as a chronic disease: approaches to long-term continuing care. Alcohol Res Health. 2011;33(4):356-370.
6. Madras BK, Compton WM, Avula D, Stegbauer T, Stein JB, Clark HW. Screening, brief interventions, referral to treatment (SBIRT) for illicit drug and alcohol use at multiple healthcare sites: comparison at intake and 6 months later. Drug Alcohol Depend. 2009;99(1-3):280-295.
7. Amato L, Minozzi S, Davoli M. Efficacy and safety of pharmacological interventions for the treatment of the alcohol withdrawal syndrome. Cochrane Database Syst Rev. 2011;(6):CD008537.
8. Kaner EFS, Beyer F, Dickinson HO, et al. Effectiveness of brief alcohol interventions in primary care populations. Cochrane Database Syst Rev. 2007;(2):CD004148.
9. Rösner S, Hackl-Herrwerth A, Leucht S, Vecchi S, Srisurapanont M, Soyka M. Opioid antagonists for alcohol dependence. Cochrane Database Syst Rev. 2010;(12):CD001867.
10. Mattick RP, Kimber J, Breen C, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev. 2008;(2):CD002207.
11. Mangione CM, Gerzoff RB, Williamson DF, et al TRIAD Study Group. The association between quality of care and the intensity of diabetes disease management programs. Ann Intern Med. 2006;145(2):107-116. (Pubitemid 46780584)
12. Sochalski J, Jaarsma T, Krumholz HM, et al. What works in chronic care management: the case of heart failure. Health Aff (Millwood). 2009;28(1):179-189.
13. Katon W, Russo J, Lin EH, et al. Cost-effectiveness of a multicondition collaborative care intervention: a randomized controlled trial. Arch Gen Psychiatry. 2012;69(5):506-514.
14. Joseph AM, Fu SS, Lindgren B, et al. Chronic disease management for tobacco dependence: a randomized, controlled trial. Arch Intern Med. 2011;171(21):1894-1900.
15. Saitz R, Cheng DM, Winter M, et al. Chronic care management for dependence on alcohol and other drugs: the AHEAD randomized trial. JAMA. doi:10.1001/jama.2013.277609.
16. Rothe U, Müller G, Schwarz PE, et al. Evaluation of a diabetes management system based on practice guidelines, integrated care, and continuous quality management in a federal state of Germany: a population-based approach to health care research. Diabetes Care. 2008;31(5):863-868.
17. Weisner C, Mertens J, Parthasarathy S, Moore C, Lu Y. Integrating primary medical care with addiction treatment: a randomized controlled trial. JAMA. 2001;286(14):1715-1723. (Pubitemid 33010257)
18. Bernstein JA, Bernstein E, Heeren TC. Mechanisms of change in control group drinking in clinical trials of brief alcohol intervention: implications for bias toward the null. Drug Alcohol Rev. 2010;29(5):498-507.